Skip to content

Author

Y. Kobbi

We have 2 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Ivabradine in cardiogenic shock with catecholamine weaning failure: focus on the atrial fibrillation subpopulation

The management of cardiogenic shock (CS) and failure of catecholamine weaning is challenging, particularly in patients with concomitant atrial fibrillation (AF). Because ivabradine primarily acts on the sinus node, its role in patients with AF remains uncertain. We therefore specifically evaluated the hemodynamic...

O. Haddar, S. Charfeddine, Y. Kobbi et al. · 0 citations
Open access Oct 2026

Ivabradine for hemodynamic optimization and catecholamine weaning in cardiogenic shock: a retrospective cohort study

Heart rate control may represent a key therapeutic target in cardiogenic shock (CS), particularly in patients who experience failure of catecholamine weaning. Ivabradine, a selective sinus node inhibitor, could improve ventriculo-arterial coupling and hemodynamic stability; however, clinical data in this setting...

O. Haddar, S. Charfeddine, Y. Kobbi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.